Genomics Symposium 2018

Thursday, October 25

Hyatt Regency Cambridge | Cambridge, MA

Miniaturize, Accelerate, and Maximize Your Research with Acoustic Liquid Handling

Join Us for Genomics Symposium 2018 in Cambridge, MA

We are excited to share with you our upcoming Genomics Symposium at the Hyatt Regency Cambridge. The symposium will bring together leading scientists from Johns Hopkins School of Medicine, Ginkgo Bioworks, New York University Langone Health, Guy's and St Thomas' NHS, Scripps Institution of Oceanography - University of California San Diego, and HiFiBiO Therapeutics to share their work and discuss how acoustic liquid dispensing is enabling their research across multiple genomics applications.

Seats are limited, so register today!


10:00 AM - 6:00 PM
Location: Hyatt Regency Cambridge

Writing Eukaryotic Genomes

Dr. Leslie Mitchell | Post Doctoral Fellow, New York University Langone Health

About Dr. Mitchell

Leslie Mitchell received her PhD from the University of Ottawa in Canada. She is currently a postdoctoral fellow in the lab of Jef Boeke at NYU Langone Health and co-founder of a biotech startup, Neochromosome, focused on developing new human therapies using genome writing technology. She has worked extensively on chromosome and genome engineering in both yeast and mammalian systems and helps lead the international Synthetic Yeast Genome Project, Sc2.0 (, which aims to build a designer yeast genome from scratch.

Alicja Gomes

Echo-enabled High-throughput Strain Engineering

Alicja Gomes | Build Engineer, Ginkgo Bioworks

About Alicja

Alicja Gomes is a Build Engineer at Ginkgo Bioworks, The Organism Company, where she builds high throughput molecular biology pipelines with the mission of making biology easier to engineer. Hailing from Warsaw, Poland, she graduated with a degree in biotechnology from Adam Mickiewicz University, where she found her love for the biotech industry while concocting fermented beer in her microbiology classes. At Ginkgo, Alicja uses custom software and highly sophisticated hardware automation to construct thousands of strains of yeast and bacteria, creating better ways to produce flavors, fragrances, and enzymes through fermentation. She’s passionate about what we can accomplish with the power of synthetic biology. She loves to travel and explore new cultures. Her goal for the next summer is to travel to Peru and to hike Mt. Washington with her dog Ozzy.

Single Cell mRNAseq on Labcyte Echo 525

Dr. Alka Saxena | Head of Genomics Research, Guy's and St Thomas' NHS

About Dr. Saxena

Dr. Alka Saxena studied medicine at Shivaji University, India. After seven years of clinical practice, Alka completed her Ph.D. at Melbourne University Australia and studied monogenic disorders at the University of Western Australia, where she became an Assistant Professor. She continued investigations on monogenic disorders and basic science using systems biology approaches at RIKEN Institute in Yokohama Japan where she participated in the FANTOM5 consortium. Since 2013 Alka has been Head of Genomics at the NIHR Guy’s and St Thomas’ BRC and Honorary Senior Research Fellow at King’s College London. Alka’s team develop, optimise and benchmark cutting-edge Genomics protocols including methods for single cell investigations.

Alka is co-founder of the Samartha Saxena Foundation, a charitable Trust established in her son’s memory.

Xitiz Chamling

Use of Genome Engineered Human Pluripotent Stem Cells for Small Molecule Screening

Dr. Xitiz Chamling | Post Doctoral Fellow, Johns Hopkins University School of Medicine

About Dr. Chamling

Xitiz Chamling, Ph.D. is a postdoctoral fellow in Dr. Donald J. Zack’s laboratory at the Johns Hopkins University School of Medicine. Dr. Chamling completed his Ph.D. in genetics at the University of Iowa under mentorship of Dr. Val C. Sheffield, a HHMI professor. Key aspect of his ongoing work in Dr. Zack’s laboratory is to use human pluripotent stem cell-derived oligodendrocytes (OLs) and retinal ganglion cells (RGCs) as models to study OL development, maturation, and mechanisms by which they myelinate CNS neurons. By combining the stem cell and the CRIPSR-Cas9 genome editing technologies he has generated reporter-stem cell lines that express reporter proteins driven by endogenous OL or RGC specific genes. Working with other members of Zack lab, Dr. Chamling has used these reporters-cell lines and established human RGC and human OL based drug screening platform to identify neuroprotective and myelination promoting bioactive molecules.

Discovering the Next Generation of Immunomodulatory Antibodies, One B Cell at a Time

Dr. Pascaline Mary | Associate Director, HiFiBiO Therapeutics

About Dr. Mary

Pascaline Mary is leading the global efforts at HiFiBiO to advance the company’s unique antibody screening platform. Over the past 12 years, she has worked in developing biological assays and technologies using microfluidic tools for academic and industrial applications. Previously, Pascaline was a group leader in molecular biology at GnuBIO, a next-generation DNA sequencing company, acquired by Bio-Rad in 2014. Before joining GnuBIO, Pascaline was a postdoc in the Weitz lab at Harvard University. Pascaline graduated from ESPCI (France) and Ecole Normale Superieure (France) in Physics. She received her master’s degree at University Pierre et Marie Curie (France) in soft matter physics and then re-joined the Microfluidics, Mems and Nanostructures (MMN) lab at ESPCI to complete her PhD at the renowned microfluidic engineering and molecular biology institution.

Matthieu Delince

Matthieu Delince | Scientist, HiFiBiO Therapeutics

About Matthieu

Matthieu Delince has a bachelor and master’s degree in bioengineering from the Swiss Federal Institute of Technology in Lausanne (EPFL). He subsequently completed a PhD at EPFL investigating the role of cellular individuality during infection by developing a microfluidic device to do long-term single-cell time-lapse microscopy.

He then joined the lab of Tomas Kirchhausen at the Harvard Medical school, where he worked on an in vitro blood-brain barrier model to characterize the transport of antibodies by transcytosis using high spatio-temporal microscopy.

Matt is currently a scientist at HiFiBiO Therapeutics leading the single-cell screening team in Cambridge.

Jeremiah Minich

Leveraging Advances in ‘Omics’ and Biotechnology to Decipher Marine Microbial Ecology: Applications to Fisheries and Aquaculture

Jeremiah Minich | Ph.D. Student, Scripps Institute of Oceanography, UCSD

About Jeremiah

Jeremiah Minich is a Ph.D. student in Marine Biology at Scripps Institute of Oceanography advised by Rob Knight and Eric Allen. His primary interest is in solving food security problems through sustainable aquaculture. Microbes intricately linked to aquatic host health through disease and nutrition. By studying these interactions in natural settings, we can develop and then test hypotheses experimentally. To begin answering these questions, Jeremiah has helped develop methods for high throughput metagenomics for diverse sample types including low biomass samples. He continue to seek out new and interesting opportunities in biotechnology and genomics with an eye to aquaculture applications.

6:00 PM - 8:30 PM

Networking Dinner Event